[1]史静怡,丁邵祥,赵志林,等.冠状动脉慢血流与外周血淋巴细胞和单核细胞比值之间的关联性分析[J].现代检验医学杂志,2020,35(01):139-142.[doi:10.3969/j.issn.1671-7414.2020.01.037]
　SHI Jing-yi,DING Shao-xiang,ZHAO Zhi-lin,et al.Association of Slow Coronary Flow with Peripheral Blood Lymphocyte-to-Monocyte Ratio[J].Journal of Modern Laboratory Medicine,2020,35(01):139-142.[doi:10.3969/j.issn.1671-7414.2020.01.037]
点击复制

冠状动脉慢血流与外周血淋巴细胞和单核细胞比值之间的关联性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年01期
页码:
139-142
栏目:
检验与临床
出版日期:
2020-02-29

文章信息/Info

Title:
Association of Slow Coronary Flow with Peripheral Blood Lymphocyte-to-Monocyte Ratio
文章编号:
1671-7414(2020)01-139-05
作者:
史静怡1; 丁邵祥2; 赵志林2; 王 炯3
(1.西安市第三医院心内科,西安 710021; 2.咸阳市第一人民医院心血管内一科,陕西咸阳 712000; 3.凤翔县中医医院检验科, 陕西宝鸡 721400)
Author(s):
SHI Jing-yi1; DING Shao-xiang2; ZHAO Zhi-lin2; WANG Jiong3
(1. Department of Cardiology,the Third Hospital of Xi' an, Xi' an 710021,China; 2. Department of Cardiovascular Medicine, the First People's Hospital of Xianyang City,Shaanxi Xianyang 712000,China; 3.Department of Clinical Laboratory,Fengxiang County Hospital of Traditional Chinese Medicine,Shaanxi Baoji 721400, China)
关键词:
冠状动脉慢血流;  淋巴细胞和单核细胞比值;  炎性标志物;  冠状动脉造影;  关联性分析
分类号:
R541; R446.11
DOI:
10.3969/j.issn.1671-7414.2020.01.037
文献标志码:
A
摘要:
目的 探究淋巴细胞和单核细胞比值(lymphocyte-to-monocyte ratio, LMR)与冠状动脉慢血流(slow coronary flow, SCF)现象之间的关联性。方法 回顾性收集98例2016年9月～2017年11月在凤翔县中医医院因可疑有冠状动脉疾病,行冠状动脉造影检查的患者为研究对象。采用血液分析仪进行全血细胞计数。采用数字血管造影系统,基于心肌梗死后的血栓溶栓(thrombolysis in myocardial infarction, TIMI)计帧法检测冠状动脉血流量。根据冠状动脉造影结果将研究对象分为两组,包括45例SCF患者组和53例正常冠状动脉血流健康(normal coronary flow, NCF)对照组。采用Logistic回归分析LMR与SCF发生之间的关联性。结果 相比NCF患者,SCF患者组的高密度脂蛋白胆固醇(high-density lipoprotein cholesterol, HDL-C)水平、嗜中性粒细胞、单核细胞计数,嗜中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio, NLR),C-反应蛋白(C-reactive protein, CRP)和心肌梗死后的血栓溶栓(thrombolysis in myocardial infarction, TIMI)帧数较高,但淋巴细胞计数和LMR较低,差异均有统计学意义(t=1.630～7.834, 均P<0.05)。LMR与左前降支(left anterior descending, LAD)动脉,左回旋支(left circumflex, LCX)侧动脉和右冠状(right coronary artery, RCA)动脉的TIMI帧数呈现负向关联性(r=-1.31,-1.05和-0.76,均P<0.001)。LMR单变量(OR=0.76, 95%CI=0.57～0.93,P=0.003)和多变量(OR=0.32, 95%CI=0.14～0.91,P=0.011)。logistic回归分析均发现LMR的升高与SCF的发生风险呈现负向关联性。结论 LMR与SCF的发生风险呈现负向关联性,可以作为SCF发生的一种预测性标志物。
Abstract:
Objective To investigate the association between lymphocyte-to-monocyte ratio(LMR)and slow coronary flow(SCF)phenomenon. Methods A total of 98 patients who had performed coronary angiography for suspected coronary artery disease, were retrospectively enrolled in the present study from June 2016 to November 2017 in Fengxiang Hospital. Whole blood counts were performed using a blood analyzer. Coronary blood flow was measured by a digital angiography system based on thrombolysis in myocardial infarction(TIMI)frame counting method after myocardial infarction. According to the results of coronary angiography, all subjects were divided into two groups, including 45 SCF patients and 53 normal coronary flow(NCF)controls. Logistic regression was used to analyze the association between LMR and SCF. Results Higher level of HDL, neutrophils and monocyte counts, neutrophil-to-lymphocyte ratio(NLR), C-reactive protein(CRP)and thrombolysis in myocardial infarction(TIMI)frame counts, and lower level of lymphocyte counts were found among SCF group than NCF group,the difference was statistically significant(t=1.630～7.834, all P<0.05). LMR was negatively associated with frame counts of left anterior descending(LAD), left circumflex artery(LCX)and right coronary artery(RCA)(r= -1.31,-1.05, -0.76, all P<0.001). In addition, increased LMR was negatively associated with risk of SCF in both univariate(OR=0.76, 95%CI=0.57～0.93,P=0.003)and multiple(OR=0.32, 95%CI=0.14～0.91,P=0.011)logistic regression models. Conclusion LMR was negatively associated with risk of SCF, and LMR may play as a predictive biomarker of incident SCF.

参考文献/References:

[1] NIU Hongmei, WEI Zhenzhen, ZHANG Yanling, et al. Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow[J]. Experimental and Therapeutic Medicine, 2018, 15(1): 904-908.
[2] MUTLUER F O, URAL D, GUNGOR B, et al. Association of interleukin-1 gene cluster polymorphisms with coronary slow flow phenomenon[J]. Anatolian Journal of Cardiology, 2018, 19(1): 34-41.
[3] YALTA K, YALTA T. Physically triggered takotsubo cardiomyopathy has a worse prognosis: Potential roles of systemic inflammation and coronary slow flow phenomenon[J]. International Journal of Cardiology, 2017, 242: 31-32.
[4] GHAFFARI S, TAJLIL A, ASLANABADI N, et al. Clinical and laboratory predictors of coronary slow flow in coronary angiography[J]. Perfusion, 2017, 32(1): 13-19.
[5] DOGAN M, AKYEL A, CIMEN T, et al. Relationship between neutrophil to lymphocyte ratio and slow coronary flow[J]. Clinical and Applied Thrombosis-Hemostasis, 2015, 21(3): 251-254.
[6] LI Chenguang, ZHANG Feng, SHEN Yi, et al. Impact of neutrophil to lymphocyte ratio(NLR)index and its periprocedural change(NLRΔ)for percutaneous coronary intervention in patients with chronic total occlusion[J]. Angiology, 2017, 68(7): 640-646.
[7] HUH J Y, ROSS G W, CHEN Randi, et al. Total and differential white blood cell counts in late life predict 8-year incident stroke: the Honolulu heart program[J]. Journal of the American Geriatrics Society, 2015, 63(3): 439-446.
[8] JI Hanhua, LI Yang, FAN Zeyuan, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment[J]. BMC Cardiovascular Disorders, 2017, 17(1): 90.
[9] ARFVIDSSON J, AHLIN F, VARGAS K G, et al. Monocyte subsets in myocardial infarction: A review[J]. International Journal of Cardiology, 2017, 231(1): 47-53.
[10] BRAININ P, FRESTAD D, PRESCOTT E. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis[J]. International Journal of Cardiology, 2018, 254: 1-9.
[11] HU Pingping, SHEN Hongchang, WANG Guanghui, et al. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study[J]. PLoS One, 2014, 9(10): e108062.
[12] HAN Lihui, JIA Yibin, SONG Qingxu, et al. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma[J]. Asian Pacific Journal of Cancer Prevention, 2015, 16(6): 2245-2250.
[13] MURAT S N, YARLIOGLUES M, CELIK I E, et al. The relationship between lymphocyte-to-monocyte ratio and bare-metal stent in-stent restenosis in patients with stable coronary artery disease[J]. Clinical and Applied Thrombosis-Hemostasis, 2017, 23(3): 235-240.
[14] KURTUL A, YARLIOGLUES M, CELIK I E, et al. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction[J]. Coronary Artery Disease, 2015, 26(8): 706-712.
[15] GIBSON C M, CANNON C P, DALEY W L, et al. TIMI frame count: a quantitative method of assessing coronary artery flow[J]. Circulation, 1996, 93(5): 879-888.
[16] KUYUMCU M S, KUYUMCU A, YAYLA C, et al. Nesfatin-1 levels in patients with slow coronary flow[J]. Kardiologia Polska, 2018, 76(2): 401-405.
[17] XU Ying, MENG Hailiang, SU Yamin, et al. Serum YKL-40 is increased in patients with slow coronary flow[J]. Coronary Artery Disease, 2015, 26(2): 121-125.
[18] CETIN M S,OZCAN CETIN E H,CANPOLAT U, et al. An overlooked parameter in coronary slow flow phenomenon: whole blood viscosity[J]. Biomark Med,2015,9(12):1311-1321.
[19] HUTTERER G C, SOBOLEV N, EHRLICH G C, et al. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma[J]. Journal of Clinical Pathology, 2015, 68(5): 351-355.
[20] 周正宇,高谦,景丽玲,等.中性粒细胞与淋巴细胞比值对初发溃疡性结肠炎鉴别诊断及其严重程度判断的临床意义[J].现代检验医学杂志,2018,33(1):145-147, 150. ZHOU Zhengyu,GAO Qian,JING Liling,et al. Clinical significance of the ratio of neutrophil to lymphocyte in the differential diagnosis of primary ulcerative colitis and the judgment of its severity [J].Journal of Modern Laboratory Medicine,2018,33(1):145-147, 150.
[21] 顾进,侯思南,许海英.中性粒细胞淋巴细胞比率在衡量肥胖病人炎症状态的初步探讨[J].现代检验医学杂志,2016,31(6):147-149. GU Jin,HOU Sinan,XU Haiying. Preliminary study on neutrophil-lymphocyte ratio as an indicator of inflammatory state in obese patients [J].Journal of Modern Laboratory Medicine,2016,31(6):147-149.
[22] CANPOLAT U, CETIN E H, CETIN S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation[J]. Clinical and Applied Thrombosis/Hemostasis, 2016, 22(5): 476-482.
[23] GARY T, PICHLER M, BELAJ K, et al. Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients[J]. Int J Clin Pract,2014,68(12):1483-1487.
[24] TAPP L D, SHANTSILA E, WRIGLEY B J, et al. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction[J]. Journal of Thrombosis and Haemostasis, 2012, 10(7): 1231-1241.
[25] DIAMANTIDIS M D, SOGKA E A. The presence of low-count chronic lymphocytic leukemia-like monoclonal B lymphocytosis in patients with Ph-myeloproliferative neoplasms: A random event or a shared causal pathobiology?[J]. Leukemia Research, 2015, 39(11): 1129-1130.
[26] WANG Xuedong, XIE Zulong, LIU Xinxin, et al. Association of platelet to lymphocyte ratio with non-culprit atherosclerotic plaque vulnerability in patients with acute coronary syndrome: an optical coherence tomography study[J]. BMC Cardiovascular Disorders, 2017, 17(1): 175.
[27] KOUNIS N G, SOUFRAS G D, TSIGKAS G, et al. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease[J]. Clinical and Applied Thrombosis/Hemostasis, 2015, 21(2): 139-143.

相似文献/References:

[1]徐金良a,杜丹丹,翟志敏,等.卵巢良恶性肿瘤患者血液NLR,LMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(02):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　XU Jin-lianga,DU Dan-dan,ZHAI Zhi-min,et al.Changes and Clinical Significance of Four Parameters of NLR,LMR, RDW and PLR in Patients with Benign and Malignant Ovarian Tumors[J].Journal of Modern Laboratory Medicine,2018,33(01):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]

备注/Memo

备注/Memo:
基金项目:陕西省自然科学基金项目(2013JM401)。 作者简介:史静怡(1971-),女,本科,主治医师,研究方向:心血管、心衰的研究治疗,E-mail:xishijingy@163.com。 通讯作者:赵志林(1984-),男,本科,主治医生,E-mail:zhaozhilin04@126.com。收稿日期:2019-01-14 修回日期:2019-10-30
更新日期/Last Update: 2020-03-30